Revvity EPS - Earnings per Share 2012-2025 | RVTY
Revvity annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Revvity EPS for the quarter ending September 30, 2025 was $0.40, a 48.05% decline year-over-year.
- Revvity EPS for the twelve months ending September 30, 2025 was $1.98, a 6.6% decline year-over-year.
- Revvity 2024 annual EPS was $2.2, a 60.36% decline from 2023.
- Revvity 2023 annual EPS was $5.55, a 23.33% increase from 2022.
- Revvity 2022 annual EPS was $4.5, a 44.31% decline from 2021.
| Revvity Annual EPS | |
|---|---|
| 2024 | $2.20 |
| 2023 | $5.55 |
| 2022 | $4.50 |
| 2021 | $8.08 |
| 2020 | $6.49 |
| 2019 | $2.04 |
| 2018 | $2.13 |
| 2017 | $2.64 |
| 2016 | $2.12 |
| 2015 | $1.87 |
| 2014 | $1.39 |
| 2013 | $1.47 |
| 2012 | $0.61 |
| 2011 | $0.07 |
| Revvity Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.40 |
| 2025-06-30 | $0.46 |
| 2025-03-31 | $0.35 |
| 2024-12-31 | $0.77 |
| 2024-09-30 | $0.77 |
| 2024-06-30 | $0.45 |
| 2024-03-31 | $0.21 |
| 2023-12-31 | $0.69 |
| 2023-09-30 | $0.08 |
| 2023-06-30 | $0.28 |
| 2023-03-31 | $4.50 |
| 2022-12-31 | $1.01 |
| 2022-09-30 | $0.67 |
| 2022-06-30 | $1.42 |
| 2022-03-31 | $1.40 |
| 2021-12-31 | $1.41 |
| 2021-09-30 | $1.11 |
| 2021-06-30 | $2.19 |
| 2021-03-31 | $3.37 |
| 2020-12-31 | $3.39 |
| 2020-09-30 | $1.57 |
| 2020-06-30 | $1.23 |
| 2020-03-31 | $0.30 |
| 2019-12-31 | $0.58 |
| 2019-09-30 | $0.52 |
| 2019-06-30 | $0.62 |
| 2019-03-31 | $0.32 |
| 2018-12-31 | $0.64 |
| 2018-09-30 | $0.69 |
| 2018-06-30 | $0.57 |
| 2018-03-31 | $0.23 |
| 2017-12-31 | $-0.37 |
| 2017-09-30 | $0.82 |
| 2017-06-30 | $1.84 |
| 2017-03-31 | $0.35 |
| 2016-12-31 | $0.58 |
| 2016-09-30 | $0.53 |
| 2016-06-30 | $0.58 |
| 2016-03-31 | $0.43 |
| 2015-12-31 | $0.60 |
| 2015-09-30 | $0.48 |
| 2015-06-30 | $0.43 |
| 2015-03-31 | $0.36 |
| 2014-12-31 | $0.28 |
| 2014-09-30 | $0.37 |
| 2014-06-30 | $0.44 |
| 2014-03-31 | $0.30 |
| 2013-12-31 | $0.58 |
| 2013-09-30 | $0.36 |
| 2013-06-30 | $0.25 |
| 2013-03-31 | $0.28 |
| 2012-12-31 | $-0.14 |
| 2012-09-30 | $0.26 |
| 2012-06-30 | $0.29 |
| 2012-03-31 | $0.20 |
| 2011-12-31 | $-0.73 |
| 2011-09-30 | $0.32 |
| 2011-06-30 | $0.26 |
| 2011-03-31 | $0.22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.518B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $153.002B | 27.77 |
| HCA Healthcare (HCA) | United States | $114.483B | 17.75 |
| CVS Health (CVS) | United States | $99.460B | 11.44 |
| Elevance Health (ELV) | United States | $75.335B | 11.24 |
| Cencora (COR) | United States | $69.692B | 21.99 |
| Natera (NTRA) | United States | $28.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.132B | 21.37 |
| Labcorp Holdings (LH) | United States | $22.980B | 17.52 |
| Viatris (VTRS) | United States | $16.793B | 6.26 |
| Medpace Holdings (MEDP) | United States | $15.268B | 37.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.244B | 0.00 |
| Solventum (SOLV) | United States | $13.550B | 13.15 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| ICON (ICLR) | Ireland | $12.161B | 12.07 |
| CochLear (CHEOY) | Australia | $11.774B | 0.00 |
| Charles River Laboratories (CRL) | United States | $9.312B | 17.93 |
| Sonic Healthcare (SKHHY) | Australia | $7.878B | 0.00 |
| Avantor (AVTR) | United States | $7.677B | 11.73 |
| BrightSpring Health Services (BTSG) | United States | $7.156B | 42.67 |
| HealthEquity (HQY) | United States | $6.788B | 25.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.207B | 0.00 |
| PACS (PACS) | United States | $6.058B | 36.84 |
| Bausch + Lomb (BLCO) | Canada | $6.022B | 39.53 |
| Sotera Health (SHC) | United States | $5.043B | 24.32 |
| Alignment Healthcare (ALHC) | United States | $4.352B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.012B | 18.80 |
| GeneDx Holdings (WGS) | United States | $2.436B | 42.79 |
| Organon (OGN) | United States | $2.134B | 2.25 |
| Establishment Labs Holdings (ESTA) | United States | $1.999B | 0.00 |
| Progyny (PGNY) | United States | $1.892B | 37.20 |
| Pediatrix Medical (MD) | United States | $1.794B | 10.71 |
| Surgery Partners (SGRY) | United States | $1.754B | 22.60 |
| Ardent Health (ARDT) | United States | $1.280B | 4.18 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.001B | 16.36 |
| Teladoc Health (TDOC) | United States | $0.889B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.828B | 13.56 |
| Nutex Health (NUTX) | United States | $0.706B | 5.40 |
| Omada Health (OMDA) | United States | $0.675B | 0.00 |
| Embecta (EMBC) | United States | $0.643B | 3.59 |
| Sonida Senior Living (SNDA) | United States | $0.642B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.563B | 25.30 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.466B | 8.57 |
| CryoPort (CYRX) | United States | $0.437B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.409B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| So-Young (SY) | China | $0.339B | 0.00 |
| Agilon Health (AGL) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.262B | 0.00 |
| Oncology Institute (TOI) | United States | $0.257B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| LifeMD (LFMD) | United States | $0.151B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.097B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.070B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.10 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |